Given that ALDH1A1 is frequently elevated in multiple cancer and contributes to cancer cell proliferation and chemoresistance via multiple mechanisms, specific inhibition of ALDH1A1 activity is considered a promising strategy for the cancer treatment. This evidence concerns the gene ALDH1A1 and cancer.